ARCHIVES

Pazdur Waxes On Calumet City And Krebiozen; Parkinson Takes Interim CMO Job at Zyngenia

This article is from The Cancer Letter archive.

Vol. 38 No. 17 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

Clinical Trials Approved By NCI

October 31, 2003

New Drugs And Older Ones In New Uses Show Progress Against Several Cancers

April 25, 2008

Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say

May 14, 2010

Lymphoblastoid If Test Shows Toxicity Not From Impurity, Investigator Says

August 8, 1980

DCCR Community Oncology Program RFP Now Ready

April 27, 1979